STFC congratulates our colleagues Dr Paul Collier, Professor David Southwood, Dr Jessica Wade and STFC partner David Parr on being honoured in the Queen’s Birthday Honours list 2019.
STFC is currently seeking new members to sit on its Council.
Hospital superbugs such as MRSA or E.coli could soon be under attack from a new generation of drugs designed with the help of advanced computing technologies from STFC and IBM Research.
A ground-breaking new initiative aims to spark a passion for science in communities across the UK by inviting them to develop tailor-made activities in partnership with their local science centres.
STFC spin-out, The Electrospinning Company, has secured £1.5M in Series A funding which it intends to use to grow sales of existing product and develop new biomaterials.
A new compound which visualises and kills antibiotic-resistant superbugs has been discovered by UK scientists.
A HealthTec Cluster launched today at Sci-Tech Daresbury will grow successful health technology businesses, develop world firsts in medical science and deliver life-changing health innovations both in the North West and nationally.
A revolutionary 3D cell culture technology, developed in the UK, will speed up the laboratory testing process for testing new drugs and understanding diseases, whilst reducing the reliance on animal testing.
Work has begun today on a unique research building at STFC’s Rutherford Appleton Laboratory that will develop new technologies to transform our understanding of diseases and speed up drug design.
The European X-Ray Free-Electron Laser Facility (European XFEL) is now encouraging the scientific community worldwide to submit proposals for Early User Experiments via the User Portal to the European XFEL (UPEX) .
Last updated: 03 July 2019